Rep. April McClain Delaney Purchases Shares of STERIS plc (NYSE:STE)

Representative April McClain Delaney (D-Maryland) recently bought shares of STERIS plc (NYSE:STE). In a filing disclosed on October 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on September 18th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Nasdaq (NASDAQ:NDAQ) on 9/19/2025.
• Sold $1,001 – $15,000 in shares of Silicon Graphics International (NASDAQ:SGI) on 9/19/2025.
• Sold $1,001 – $15,000 in shares of Middleby (NASDAQ:MIDD) on 9/18/2025.
• Purchased $1,001 – $15,000 in shares of Brown & Brown (NYSE:BRO) on 9/18/2025.
• Purchased $1,001 – $15,000 in shares of Jones Lang LaSalle (NYSE:JLL) on 9/18/2025.
• Sold $1,001 – $15,000 in shares of Dayforce (NYSE:DAY) on 9/11/2025.
• Purchased $1,001 – $15,000 in shares of STERIS (NYSE:STE) on 9/11/2025.
• Purchased $1,001 – $15,000 in shares of BJ’s Wholesale Club (NYSE:BJ) on 8/25/2025.
• Purchased $15,001 – $50,000 in shares of Markel Group (NYSE:MKL) on 8/21/2025.
• Sold $15,001 – $50,000 in shares of Dayforce (NYSE:DAY) on 8/19/2025.

STERIS Stock Performance

STERIS stock opened at $239.47 on Friday. STERIS plc has a 12-month low of $200.98 and a 12-month high of $253.00. The company has a market capitalization of $23.59 billion, a price-to-earnings ratio of 36.67 and a beta of 1.01. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53. The firm’s fifty day moving average price is $244.15 and its 200 day moving average price is $235.70.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, August 6th. The medical equipment provider reported $2.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.32 by $0.02. STERIS had a net margin of 11.61% and a return on equity of 14.17%. The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the previous year, the firm posted $2.03 EPS. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. On average, research analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 26th. Investors of record on Thursday, September 4th were paid a dividend of $0.63 per share. This is a positive change from STERIS’s previous quarterly dividend of $0.57. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $2.52 annualized dividend and a yield of 1.1%. STERIS’s payout ratio is presently 38.59%.

Insider Activity

In other STERIS news, CEO Daniel A. Carestio sold 159 shares of the business’s stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $241.82, for a total transaction of $38,449.38. Following the completion of the transaction, the chief executive officer directly owned 51,096 shares of the company’s stock, valued at $12,356,034.72. The trade was a 0.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Renato Tamaro sold 3,204 shares of the business’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $249.24, for a total transaction of $798,564.96. Following the transaction, the vice president directly owned 7,221 shares of the company’s stock, valued at $1,799,762.04. The trade was a 30.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 18,868 shares of company stock worth $4,585,389 over the last three months. Insiders own 1.07% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on STE shares. Morgan Stanley lifted their price target on shares of STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research note on Friday, August 8th. Weiss Ratings reissued a “buy (b-)” rating on shares of STERIS in a research report on Saturday, September 27th. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 14th. Finally, KeyCorp boosted their target price on shares of STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 22nd. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $273.50.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. QRG Capital Management Inc. boosted its holdings in shares of STERIS by 122.5% in the 1st quarter. QRG Capital Management Inc. now owns 2,832 shares of the medical equipment provider’s stock valued at $642,000 after buying an additional 1,559 shares during the period. Foresight Group Ltd Liability Partnership acquired a new position in STERIS during the 1st quarter valued at about $25,958,000. Allianz Asset Management GmbH boosted its stake in STERIS by 31.9% during the 1st quarter. Allianz Asset Management GmbH now owns 102,488 shares of the medical equipment provider’s stock valued at $23,229,000 after purchasing an additional 24,809 shares during the period. Ascent Group LLC acquired a new position in STERIS during the 1st quarter valued at about $261,000. Finally, Dynamic Advisor Solutions LLC boosted its stake in STERIS by 23.6% during the 1st quarter. Dynamic Advisor Solutions LLC now owns 1,203 shares of the medical equipment provider’s stock valued at $273,000 after purchasing an additional 230 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.